FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3040681 · Received April 8, 2013

Report

Report Number
2124215-2013-01478
Event Type
Malfunction
Date Received
April 8, 2013
Date of Event
January 8, 2013
Report Date
January 8, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THROUGH A REMOTE MONITORING SYSTEM THAT THIS DEVICE DETECTED AN OUT OF RANGE SHOCK IMPEDANCE MEASUREMENT ON THE RIGHT VENTRICULAR (RV) LEAD. REVIEW OF THE DEVICE INFORMATION INDICATED NORMAL SHOCK LEAD VARIATION BETWEEN 90 AND 120 OHMS WITH THE OCCASIONAL MEASUREMENT GREATER THAN 125 OHMS. NO LEAD FRACTURE WAS SUSPECTED; THEREFORE, THE PATIENT WILL BE FOLLOWED APPROPRIATELY. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
143624 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F102

Patients

Seq Age Sex Outcome Treatment
1 F102| 0128| 0148